drugset / Trial / NCT05350085

Remimazolam in the Extraction of Impacted Wisdom Teeth

NCT05350085

RandomizedParallel-groupTriple-blindTreatment

Summary

Benzodiazepines, represented by midazolam, are often used for sedation in outpatient surgery in dentistry. However, midazolam has the problems of slow consciousness recovery and long recovery time, which brings trouble to the patients. Remimazolam is a new type of ultra short acting sedative anesthetic. Compared with other similar products, remimazolam has faster effect, rapid metabolism and has no accumulation, which may mean that compared with midazolam, remimazolam has a better clinical application prospect in dental outpatient surgery.

Timeline

Start
2022-04-18
Primary completion
2023-04-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 3 mg Intravenous
Comparator Midazolam Small molecule 6 mg Intravenous
Subject Remimazolam Small molecule 5 mg Intravenous
Subject Remimazolam Small molecule 10 mg Intravenous

Indications